Connect with us

Business

Watch CNBC’s Sunday livestream on the Iran-Israel conflict, jumping oil prices and market selloff

Published

on


[The stream is slated to start at 6:00 p.m. ET. Please refresh the page if you do not see a player above at that time.]

CNBC’s Sunday evening special livestream will prepare investors for the big week ahead amid a stock market selloff, an escalating Iran-Israel conflict and spiking oil prices.

Subscribe to CNBC on YouTube. 



Source link

Business

Tesla sends former Asia head back to China as Shanghai-made EV deliveries slump 18%

Published

on



Tesla Inc. is sending executive Tom Zhu back to China, where he led the carmaker’s entry into the country, the Wall Street Journal reported.

Zhu, one of the company’s three named executive officers, was promoted to senior vice president of automotive in April 2023, a role in which he oversaw global production, sales, deliveries, service and the company’s factories from Tesla’s Austin headquarters. He previously had been based in China, heading the carmaker’s Asia Pacific operations.

The move comes as Tesla loses ground in China’s ultra-competitive electric car market. Deliveries from its Shanghai factory, which include domestic sales as well as exports, slumped 18% in April from a year ago to 62,167 vehicles, preliminary data from China’s Passenger Car Association showed late Tuesday. The decline came even as overall new-energy passenger vehicles wholesales were estimated at 800,000 units, up around 33% from a year ago.

Tesla is facing increased competition in China from the likes of BYD Co., which offers a broad range of vehicles including the popular budget Seagull hatchback, and new entrants like tech giant Xiaomi Corp., which has received more than 76,000 orders for its SU7 EV. The U.S. automaker slashed prices again across its range late last month to help boost sales. 

In a bid to revive his company’s fortunes in China, Tesla Chief Executive Officer Elon Musk made a surprise visit to Beijing in late April, receiving in-principle approval from government officials to deploy its driver-assistance system in the country.

A person with knowledge of the matter said that Tesla was granted the approval under certain conditions and managed to clear two important hurdles: reaching a mapping and navigation deal with Chinese tech giant Baidu Inc., and meeting requirements for how it handles data-security and privacy issues.

China Daily report earlier this week said that Musk, during his recent visit, proposed testing the assisted-driving functions of its vehicles in China by deploying them as taxis. Sources indicated that the Chinese government may have offered partial support for this plan, China Daily said.

Tesla shares fell 3.8% in New York on Tuesday. After surging 15% following Musk’s Beijing visit, the stock has retraced more than half those gains, as the company deals with a myriad of issues—from sweeping job cuts to increased scrutiny of its Autopilot driver-assistance system in the U.S. 

The automaker has also seen a major staff shakeup in recent weeks. Musk announced the company would cut more than 10% of headcount globally amid a slowdown in EV sales. Several key executives have also left Tesla. 

Zhu has been based in Austin since late 2022, when he arrived to run the company’s newest plant. At one point last summer, he had 25 direct reports, including Troy Jones, Tesla’s head of North American sales. Zhu now just has 10 direct reports, almost all of whom are based in Asia, according to people familiar with the matter.

Subscribe to the Eye on AI newsletter to stay abreast of how AI is shaping the future of business. Sign up for free.



Source link

Continue Reading

Business

How generative, ChatGPT-like AI is accelerating humanoid robots

Published

on


Shenzhen-based LimX Dynamics shows off one of its humanoid robots.

Limx Dynamics

BEIJING — ChatGPT-like artificial intelligence is speeding up research and bringing humanoid robots closer to reality in China, home to many of the world’s factories.

AI has been around for decades. What’s changed with the emergence of OpenAI’s ChatGPT chatbot is the ability of AI to better understand and generate content in a human-like way. While the U.S.-based tech is not officially available in China, local companies such as Baidu have released similar chatbots and AI models.

In robotics, the development of generative AI can help machines with understanding and perceiving their environment, said Li Zhang, chief operating officer of Shenzhen-based LimX Dynamics.

About three months after joining the two-year-old startup, Li said he shortened his expectations for how long it would take LimX to produce a humanoid robot capable of not just factory work, but also helping out in a households.

Li originally expected the entire process to take eight to ten years, but now anticipates some use cases will be ready in five to seven years. “After working for a few months, I saw how various tools’ abilities were improved because of AI,” he said in Mandarin, translated by CNBC.

“It has accelerated our entire research and development cycle,” he said.

It's a myth that technology and robots take jobs away, Amazon director of global robotics says

Companies are rushing into the opportunity. OpenAI itself is backing humanoid robot startups, while Elon Musk’s Tesla is developing its own, called Optimus.

Electric car giant BYD last year invested in Shanghai-based Agibot just months after its founding, according to PitchBook.

And at a high level, Chinese state media in November published a photo of Chinese President Xi Jinping watching a humanoid robot at an exhibition center during his first trip to Shanghai since the pandemic. The robot was developed by Fourier Intelligence.

Before humanoid robots reach households, as LimX ultimately intends, factories can be a lucrative, enclosed scenario in which to deploy them.

China surpassed Japan in 2013 as the world’s largest installer of industrial robots, and now accounts for more than 50% of the global total, according to Stanford’s latest AI Index report.

Electronics, automotive and metal and machinery were the three leading sectors for industrial robot installation in China, the report said.

Impact on human jobs

When it comes fully replacing human workers, however, AI advancements alone aren’t enough.

Even if AI allows a robot to think and make decisions on par with humans, mechanical limitations are a major reason why humanoids can’t yet replace human laborers, LimX’s Li said.

One of LimX’s backers, Future Capital, has also invested in a company called Pan Motor that specializes in motors for humanoids.

Generative AI doesn’t directly help with robotic motion, pointed out Eric Xia, partner at Future Capital, an investor in LimX. But “advances in large language models can help humanoid robots with advanced task planning,” he said in Chinese, translated by CNBC.

LimX’s other investors include Lenovo Capital.

A shift toward factory robots can accelerate, once the cost-per-robot comes down.

Steve Hoffman, chairman of a startup accelerator called Founders Space, said he is working with a Chinese startup called Fastra, which he expects can begin mass robot production in one year. He said he spent time in China this year teaching local businesses how to integrate generative AI.

“We have already received six orders from research institutions,” he said, noting the startup aims to lower the cost per robot to between $50,000 to $100,000 by rollout.

“If we can hit a $50,000 price point, we can sell a lot of robots,” he said, pointing out the robots’ batteries can be charged as they work, 24 hours a day. “Could pay for the robot in a year.”

In pharmaceutical research, generative AI can reduce costs, without cutting into human labor.

“You don’t save costs in our business by having less people. You actually save costs by making fewer experiments that fail,” said Alex Zhavoronkov, chairman of the board, executive director and CEO of Insilico Medicine, which has offices in Hong Kong, New York and other parts of the world.

He noted how large pharmaceutical companies have typically had to spend thousands of dollars to replicate a molecule for testing — and would run a few thousand such tests per program. He claimed that with the help of AI, Insilico only needs to synthesize about 70 molecules per program.

The company published a paper in Nature in March claiming to have reached phase 2 clinical trials for an AI-generated drug.



Source link

Continue Reading

Business

E-gate outage causing delays across UK airports

Published

on



Heathrow, Gatwick and Manchester are among major airports impacted by a Border Force issue.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2024 World Daily Info. Powered by Columba Ventures Co. Ltd.